Depletion of Glutathione by Buthionine Sulfoximine Is Cytotoxic for Human Neuroblastoma Cell Lines via Apoptosis

This publication has 54 references indexed in Scilit:

• Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
  Journal of Clinical Oncology, 1996
• Ascorbic-acid-mediated iron release from cellular ferritin and its relation to the formation of DNA strand breaks in neuroblastoma cells
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• An in vitro bacterial model of cytotoxicity to living cells caused by dopamine and 6-hydroxydopamine oxidation at physiological pH
  Free Radical Biology & Medicine, 1991
• Treatment of High-Risk Solid Tumors of Childhood with Intensive Therapy and Autologous Bone Marrow Transplantation
  Pediatric Clinics of North America, 1991
• Neuroblastomas contain iron-rich ferritin
  Cancer, 1988
• Superoxide ion as a primary reductant in ascorbate-mediated ferretin iron release
  Free Radical Biology & Medicine, 1987
• Chemosensitization by buthionine sulfoximine in vivo
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
  Biochemical Pharmacology, 1985
• GLUTATHIONE
  Annual Review of Biochemistry, 1983
• Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line
  Biochemical Pharmacology, 1982